These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience]. Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780 [TBL] [Abstract][Full Text] [Related]
24. The effects of postmenopausal Vitamin D treatment on vaginal atrophy. Yildirim B; Kaleli B; Düzcan E; Topuz O Maturitas; 2004 Dec; 49(4):334-7. PubMed ID: 15531130 [TBL] [Abstract][Full Text] [Related]
25. Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach. Ettinger B; Hait H; Reape KZ; Shu H Menopause; 2008; 15(5):885-9. PubMed ID: 18779677 [TBL] [Abstract][Full Text] [Related]
27. [Abdominal partial resection of the vagina and colpopexy: experiences with the procedure for posthysterectomy vault prolapse in 74 cases]. Papp Z; Mezei G; Hidvégi J; Hupuczi P Orv Hetil; 2005 Dec; 146(52):2641-5. PubMed ID: 16468606 [TBL] [Abstract][Full Text] [Related]
28. Effect of estradiol valerate and levonorgestrel on vaginal health. Manonai J; Chittacharoen A; Theppisai U Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):190-3. PubMed ID: 15262354 [TBL] [Abstract][Full Text] [Related]
29. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone. Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525 [TBL] [Abstract][Full Text] [Related]
33. The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial. Manonai J; Songchitsomboon S; Chanda K; Hong JH; Komindr S Maturitas; 2006 May; 54(2):135-40. PubMed ID: 16297576 [TBL] [Abstract][Full Text] [Related]
34. An office laboratory panel to assess vaginal problems. Bertholf ME; Stafford MJ Am Fam Physician; 1985 Sep; 32(3):113-25. PubMed ID: 3898791 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of menopausal complants with polyoestriol-phosphate. Experiences with Gynäsan injections]. Bachmann FF Munch Med Wochenschr; 1971 Jan; 113(5):166-9. PubMed ID: 5107471 [No Abstract] [Full Text] [Related]
36. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women. Simon JA; Reape KZ; Wininger S; Hait H Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998 [TBL] [Abstract][Full Text] [Related]
37. [Differential diagnostic possibilities based on algorithms from histological study in cervical and vaginal diseases]. Khmel'nitskiĭ OK; Belianin VL Arkh Patol; 1981; 43(11):81-5. PubMed ID: 7316836 [TBL] [Abstract][Full Text] [Related]
38. Multifocal squamous neoplasia of the female genital tract: significance of human papillomavirus infection of the vagina after hysterectomy. Schneider A; de Villiers EM; Schneider V Obstet Gynecol; 1987 Sep; 70(3 Pt 1):294-8. PubMed ID: 2819794 [TBL] [Abstract][Full Text] [Related]
39. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy. Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H Menopause; 2009; 16(4):735-41. PubMed ID: 19252451 [TBL] [Abstract][Full Text] [Related]
40. A clinicopathologic study of vagina and cervix in DES-exposed progeny. Zerner J; Fu YS; Taxiarchis LN; Reagan JW; Richart RM Diagn Gynecol Obstet; 1980; 2(4):245-56. PubMed ID: 7215109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]